Format
Sort by

Send to

Choose Destination

Search results

Items: 12

1.

Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease.

Manzo-Silberman S, Nicaise-Roland P, Neukirch C, Tubach F, Huisse MG, Chollet-Martin S, Abergel H, Driss F, Alfaiate T, Ajzenberg N, Steg PG.

Eur Heart J Cardiovasc Pharmacother. 2016 Aug 5. pii: pvw018. [Epub ahead of print]

2.

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium.

Riegger J, Byrne RA, Joner M, Chandraratne S, Gershlick AH, Ten Berg JM, Adriaenssens T, Guagliumi G, Godschalk TC, Neumann FJ, Trenk D, Feldman LJ, Steg PG, Desmet W, Alfonso F, Goodall AH, Wojdyla R, Dudek D, Philippi V, Opinaldo S, Titova A, Malik N, Cotton J, Jhagroe DA, Heestermans AA, Sinnaeve P, Vermeersch P, Valina C, Schulz C, Kastrati A, Massberg S; Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Investigators.

Eur Heart J. 2016 May 14;37(19):1538-49. doi: 10.1093/eurheartj/ehv419. Epub 2015 Aug 30.

3.

Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement.

Feldman L, Tubach F, Juliard JM, Himbert D, Ducrocq G, Sorbets E, Triantafyllou K, Kerner A, Abergel H, Huisse MG, Roussel R, Esposito-Farèse M, Steg PG, Ajzenberg N.

Am Heart J. 2014 Dec;168(6):940-7.e5. doi: 10.1016/j.ahj.2014.08.014. Epub 2014 Sep 16.

PMID:
25458659
4.

Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry.

Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox K, Hu D, Shalnova S, Steg PG; CLARIFY Registry Investigators.

Eur J Prev Cardiol. 2015 Aug;22(8):1056-65. doi: 10.1177/2047487314547652. Epub 2014 Aug 21.

PMID:
25147344
5.

Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.

Tendera M, Fox K, Ferrari R, Ford I, Greenlaw N, Abergel H, Macarie C, Tardif JC, Vardas P, Zamorano J, Gabriel Steg P; CLARIFY Registry Investigators.

Int J Cardiol. 2014 Sep;176(1):119-24. doi: 10.1016/j.ijcard.2014.06.052. Epub 2014 Jul 5.

PMID:
25042656
6.

Travelers with cutaneous leishmaniasis cured without systemic therapy.

Morizot G, Kendjo E, Mouri O, Thellier M, Pérignon A, Foulet F, Cordoliani F, Bourrat E, Laffitte E, Alcaraz I, Bodak N, Ravel C, Vray M, Grogl M, Mazier D, Caumes E, Lachaud L, Buffet PA; Cutaneous Leishmaniasis French Study Group.

Clin Infect Dis. 2013 Aug;57(3):370-80. doi: 10.1093/cid/cit269. Epub 2013 Apr 30.

7.

Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease.

Ferrari R, Abergel H, Ford I, Fox KM, Greenlaw N, Steg PG, Hu D, Tendera M, Tardif JC; CLARIFY Investigators.

Int J Cardiol. 2013 Sep 10;167(6):2938-43. doi: 10.1016/j.ijcard.2012.08.013. Epub 2012 Sep 15.

PMID:
22985742
8.

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry.

Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kääb S, Abergel H, Fox KM, Ferrari R; CLARIFY Registry Investigators.

Eur Heart J. 2012 Nov;33(22):2831-40. doi: 10.1093/eurheartj/ehs289. Epub 2012 Aug 26.

9.

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.

10.

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR; RIVAL trial group.

Lancet. 2011 Apr 23;377(9775):1409-20. doi: 10.1016/S0140-6736(11)60404-2. Epub 2011 Apr 4. Erratum in: Lancet. 2011 Apr 23;377(9775):1408. Lancet. 2011 Jul 2;378(9785):30.

PMID:
21470671
11.

Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.

FUTURA/OASIS-8 Trial Group, Steg PG, Jolly SS, Mehta SR, Afzal R, Xavier D, Rupprecht HJ, López-Sendón JL, Budaj A, Diaz R, Avezum A, Widimsky P, Rao SV, Chrolavicius S, Meeks B, Joyner C, Pogue J, Yusuf S.

JAMA. 2010 Sep 22;304(12):1339-49. doi: 10.1001/jama.2010.1320. Epub 2010 Aug 31.

PMID:
20805623
12.

The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.

Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KA, Goldberg RJ, Anderson FA Jr; Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators.

Am Heart J. 2009 Aug;158(2):193-201.e1-5. doi: 10.1016/j.ahj.2009.06.003.

PMID:
19619694
Items per page

Supplemental Content

Loading ...
Write to the Help Desk